Adeyemi Adenola M.D.

Adeyemi Adenola MD, MPH has a diverse work experience in the medical field. Currently, Adeyemi is working as a Medical Director of Clinical Science at Pfizer since 2023. Before joining Pfizer, Adeyemi worked at Global Blood Therapeutics as a Medical Director of Clinical Science starting from 2022.

In 2021, Adeyemi worked at Merck as a Clinical Scientist specializing in Oncology. In this role, Adeyemi was responsible for developing regulatory document deliverables and contributing to regulatory and medical writing for the oncology portfolio.

Prior to Merck, Adeyemi served as the Director of Research and Development at Claire Technologies from 2016 to 2020. Adeyemi provided scientific oversight and developed scientific content and strategy efforts.

From 2015 to 2015, Adeyemi worked at Charles House Association as a Senior Team Member, where they provided medical support and laboratory assessments for disease state management.

Adeyemi's earlier work experience includes being a Clinical Research Associate at the University of North Carolina at Chapel Hill from 2013 to 2014. They collaborated with key opinion leaders for research goals and participated in the drafting and review of medical monitoring plans and clinical study data.

Before moving to the United States, Adeyemi worked as a Physician at General Hospital Lagos from 2011 to 2011, at Kelina Hospital Abuja Nigeria from 2010 to 2011, and at Maitama District Hospital from 2009 to 2010.

Adeyemi Adenola MD, MPH completed a Master of Public Health (MPH) degree in Health Care Policy and Management from UNC Gillings School of Global Public Health in 2020. In 2021, they joined the National Medical Fellowship for the Diversity in Clinical Trials Research Program (NMF Dctr) but the end year is not specified. Prior to that, they obtained a certification from the Education Commission for Foreign Medical Graduates in 2014. They also hold a Doctor of Medicine and Surgery degree from Olabisi Onabanjo University(O.O.U) in 2008 and a Bachelor of Science degree in Biological Sciences from the same institution in 2001. Adeyemi Adenola has additional certifications in Interpretation and Application of ICH E6(R2) from The MRCT Center of Brigham and Women's Hospital and Harvard in 2021, Design and Interpretation of Clinical Trials from John Hopkins University in 2020, and ECFMG from the Medical Education Commission.